Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... allogeneic stem cell transplant : 5.1.2.1 Chronic myelogenous leukemia (CML): Subjects under the age of 21 in chronic phase OR ... in accelerated phase or blast transformation. OR 5.1.2.2 Acute lymphoblastic leukemia (ALL): any of these categories: Adult ALL ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  2. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    ... puberty) and 40 years of age. These patients must have acute myelogenous leukemia , acute lymphocytic leukemia, or ...

    Clinical Trial last updated 04/28/2016 - 11:14am.

  3. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... suitably matched related or unrelated donor . Acute myelogenous leukemia (AML): Complete first remission (CR1) at high risk ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  4. James M. Rossetti, DO

    ... with particular interest in myeloid malignancy, acute myelogenous leukemia , myelodysplasia, and cellular therapy. He is ...

    Bio last updated 03/11/2016 - 1:41pm.

  5. Stephen D. Nimer, MD

    ... patients with myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML), multiple myeloma, and lymphoma for over three ...

    Bio last updated 03/11/2016 - 1:41pm.

  6. Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

    ... see how well they work in treating patients with high-risk acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelogenous leukemia (CML) that has returned after a period of improvement ...

    Clinical Trial last updated 04/29/2016 - 10:34am.

  7. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... or transfusion dependence, RAEB-1 and RAEB-2 and Acute myelogenous leukemia (AML) evolved from MDS, who are not eligible for ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  8. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... transfusion dependence as well as RAEB-1 and RAEB-2 and Acute myelogenous leukemia (AML) evolved from MDS, who are not eligible for ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  9. Nonmyeloablative Haploidentical Transplant Followed by MLN9708

    ... One of the following high-risk malignancies: Chronic Myelogenous Leukemia (chronic phase, resistant and/or intolerant to tyrosine ... phase following induction chemotherapy ) Acute Myelogenous Leukemia (2nd or subsequent complete remission [CR] (OR) ...

    Clinical Trial last updated 04/29/2016 - 1:05pm.

  10. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... or low-likelihood of finding a matched, unrelated donor Acute leukemias (includes T lymphoblastic lymphoma); remission is defined as < ... Presence of extramedullary disease Acute myelogenous leukemia in high risk CR1 as defined by at least one of the ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.